ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Burzynski Research Institute (PK)

Burzynski Research Institute (PK) (BZYR)

0,05
0,00
(0,00%)
Fermé 21 Janvier 10:00PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
0,05
Prix Achat
0,03
Prix Vente
0,0598
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,013 Plage de 52 semaines 0,077
Cap du marché
Clôture Veille
0,05
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
10 325
Actions en circulation
131 448 444
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-4,90
Bénéfice par action (BPA)
-0,01
Chiffre d'affairess
-
Bénéfice net
-1,34M

À propos de Burzynski Research Institute (PK)

Secteur
In Vitro,in Vivo Diagnostics
Industrie
In Vitro,in Vivo Diagnostics
Siège social
Wilmington, Delaware, USA
Fondé
-
Burzynski Research Institute (PK) est coté dans le secteur In Vitro,in Vivo Diagnostics de la OTCMarkets avec le ticker BZYR. Le dernier cours de clôture d'Burzynski Research Insti... (PK) était de US$0,05. Au cours de la dernière année, les actions de Burzynski Research Insti... (PK) ont été négociées dans une fourchette de prix de US$ 0,013 à US$ 0,077.

Burzynski Research Insti... (PK) compte actuellement 131 448 444 actions en circulation. La capitalisation boursière d'Burzynski Research Insti... (PK) est de US$6,57 million. Burzynski Research Insti... (PK) a un ratio cours/bénéfice (ratio PE) de -4.90.

BZYR Dernières nouvelles

Burzynski Research Institute, Inc. Announces Publication of Phase II Results in Patients with Non-Diffuse Intrinsic Pontine G...

Burzynski Research Institute, Inc., a biopharmaceutical company dedicated to the development and commercialization of novel therapies for patients with brain and brainstem tumors and other...

Burzynski Research Institute, Inc. Announces Publication of Phase II Results in Adults with Newly-Diagnosed Anaplastic Astroc...

Burzynski Research Institute, Inc., a biopharmaceutical company dedicated to the development and commercialization of novel therapies for patients with rare brain tumors and other cancers...

Burzynski Research Institute, Inc. Announces Publication of Phase 2 Clinical Study in Metastatic Colon Adenocarcinoma of the ...

Burzynski Research Institute, Inc. Announces Publication of Phase 2 Clinical Study in Metastatic Colon Adenocarcinoma of the Liver PR Newswire HOUSTON, March 26, 2015 HOUSTON, March 26, 2015...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.0095123.48728081010.040490.050.040495000.045245CS
4000.050.050.03145600.04629634CS
120.00819.04761904760.0420.05450.031103250.04085009CS
260.00819.04761904760.0420.0770.031223400.05414821CS
52-0.00205-3.938520653220.052050.0770.013162420.04674988CS
1560.0266.66666666670.030.15750.013289350.04216942CS
2600.0369281.6793893130.01310.15750.0061230540.03806995CS

BZYR - Frequently Asked Questions (FAQ)

What is the current Burzynski Research Insti... (PK) share price?
The current share price of Burzynski Research Insti... (PK) is US$ 0,05
How many Burzynski Research Insti... (PK) shares are in issue?
Burzynski Research Insti... (PK) has 131 448 444 shares in issue
What is the market cap of Burzynski Research Insti... (PK)?
The market capitalisation of Burzynski Research Insti... (PK) is USD 6,57M
What is the 1 year trading range for Burzynski Research Insti... (PK) share price?
Burzynski Research Insti... (PK) has traded in the range of US$ 0,013 to US$ 0,077 during the past year
What is the PE ratio of Burzynski Research Insti... (PK)?
The price to earnings ratio of Burzynski Research Insti... (PK) is -4,9
What is the reporting currency for Burzynski Research Insti... (PK)?
Burzynski Research Insti... (PK) reports financial results in USD
What is the latest annual profit for Burzynski Research Insti... (PK)?
The latest annual profit of Burzynski Research Insti... (PK) is USD -1,34M
What is the registered address of Burzynski Research Insti... (PK)?
The registered address for Burzynski Research Insti... (PK) is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Burzynski Research Insti... (PK) website address?
The website address for Burzynski Research Insti... (PK) is www.burzynskiresearch.com
Which industry sector does Burzynski Research Insti... (PK) operate in?
Burzynski Research Insti... (PK) operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TMGIMarquie Group Inc (PK)
US$ 0,0002
(19 900,00%)
4,03M
SEANSAEAN Group Inc (PK)
US$ 1,87
(18 600,00%)
100
ZPASZoompass Holdings Inc (CE)
US$ 0,0001
(9 900,00%)
675
GMPRGourmet Provisions International Corporation (PK)
US$ 0,0001
(9 900,00%)
35,31M
PLPLPlandai Biotechnology Inc (PK)
US$ 0,0001
(9 900,00%)
18,06M
STNXStartronix International Inc (CE)
US$ 0,000001
(-99,99%)
450
AWINAERWINS Technologies Inc (CE)
US$ 0,000001
(-99,97%)
2,03k
ISOLImage Software Inc (CE)
US$ 0,000001
(-99,91%)
59,2k
NBIONascent Biotech Inc (CE)
US$ 0,0002
(-99,55%)
8,7k
FHBCFernhill Beverage Inc (CE)
US$ 0,000001
(-99,24%)
10k
GTCHGBT Technologies Inc (PK)
US$ 0,0001
(0,00%)
349,77M
VTXBVortex Brands Company (PK)
US$ 0,0002
(0,00%)
297,52M
EMEDElectroMedical Technologies Inc (PK)
US$ 0,0002
(0,00%)
233,53M
PHILPHI Group Inc (PK)
US$ 0,0002
(-33,33%)
184,12M
HMBLHUMBL Inc (PK)
US$ 0,0009
(-5,26%)
179,2M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock